Linyu Xu

Prof. Linyu Xu

Fujian medical university

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Bone
Verified
Journal Article
Closed access
SCSenxin Cai
Senxin Cai
YZYuchun Zou
Yuchun Zou
YZYong Zhao
Yong Zhao
HLHanyu Lin
Hanyu Lin
DZDali Zheng
Dali Zheng
YLYou-Guang Lu
You-Guang Lu

23 July 2025 in Pharmacological Research
Verified
Journal Article
Open access
JCJiayi Cai
Jiayi Cai
ZCZhonghan Chen
Zhonghan Chen
XYXinhan Yang
Xinhan Yang
JCJing Wen Cai
Jing Wen Cai
LCLinxin Chen
Linxin Chen
LXLinyu Xu
Linyu Xu
Osteoarthritis (OA) is a debilitating disease, that imposes a heavy burden on individuals, society, and the healthcare systems. Despite extensive research, the precise pathogenesis of OA remains incompletely defined, hindering the development of targeted therapies. Elucidating OA's molecular mechanisms is fundamental to precision medicine, as it enables identification of diagnostic and prognostic biomarkers while informing tailored treatment strategies. Current clinical guidelines prioritize conservative, non-invasive approaches, however, these demonstrate limited efficacy in halting or reversing disease progression. Within this context, mitochondrial dysfunction has emerged as a critical pathological driver in OA. Specifically, abnormal release of mitochondrial metabolites and components-functioning as damage-associated molecular patterns (mtDAMPs)-triggers inflammatory cascades that accelerate joint degeneration. These mtDAMPs additionally serve as dynamic biomarkers, with their release kinetics correlating with structural deterioration severity. Consequently, mitochondria-targeted therapies restoring mitochondrial quality control represent promising disease-modifying interventions. Here we discuss the origins and roles of key mtDAMPs (mtROS/mtDNA) in OA pathogenesis; their diagnostic and prognostic utility; and therapeutic strategies targeting mitochondrial homeostasis to mitigate OA progression.

21 February 2022 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YZYuchun Zou
Yuchun Zou
SCSenxin Cai
Senxin Cai
HLHanyu Lin
Hanyu Lin
JCJingwen Cai
Jingwen Cai
DZDa‐Li Zheng
Da‐Li Zheng
LXLinyu Xu
Linyu Xu

11 February 2022 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
YZYuchun Zou
Yuchun Zou
HLHanyu Lin
Hanyu Lin
WCWeijia Chen
Weijia Chen
LCLin Chang
Lin Chang
SCSenxin Cai
Senxin Cai
LXLinyu Xu
Linyu Xu
Background: We report a case and its 4-year follow-up of Osteoglophonic dysplasia (OD), a rare disease that disturbs both skeletal and dental development, which is usually caused by heterozygous FGFR1 mutations. Case presentation: This article presents a case where a 6-year-old male patient suffered dysregulation of tooth eruption and was diagnosed with osteogenic dysplasia from a fibroblast growth factor receptor 1 (FGFR1) heterozygote mutation. However, the number of teeth is within the normal range, and their roots are well developed. Several interventions were implemented with varying degrees of results. The details of the 4-year follow-up showed that the signs of OD were more pronounced, including dwarfism, frontal bossing, delayed skeletal maturation, anteverted nares, micrognathia, and prominent ears, but the patient’s impacted teeth and edentulous jaws remained unchanged. Conclusions: FGFR1 heterozygote mutation and OD present significant difficulty for teeth eruption and subsequent intervention. Further measures ought to be taken in recognizing various symptoms presented by the patient. This case supports the significance of careful inquiry, comprehensive physical examination and correct diagnosis as indispensable steps for clinical practice in patients with unerupted teeth. Additionally, the detailed case and its 4-year follow-up length may provide new insights into osteogenic dysplasia and patients with impacted teeth while encouraging further exploration in treatment methods.

27 May 2022 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
YZYuchun Zou
Yuchun Zou
HLHanyu Lin
Hanyu Lin
JCJingwen Cai
Jingwen Cai
QXQingqi Xie
Qingqi Xie
WCWeijia Chen
Weijia Chen
LXLinyu Xu
Linyu Xu

5 July 2024 in Annals of Anatomy - Anatomischer Anzeiger
Verified
Journal Article
Closed access
YZYuchun Zou
Yuchun Zou
PHPengcheng Huang
Pengcheng Huang
HLHanyu Lin
Hanyu Lin
ZDZhenzhen Dai
Zhenzhen Dai
XDXiran Dai
Xiran Dai
LXLinyu Xu
Linyu Xu